浅述干细胞治疗慢性肾疾病的潜力
作者:
作者单位:

复旦大学附属公共卫生临床中心,上海 201508

中图分类号:

R-33


A brief review on the development of stem cells as therapeutics for chronic kidney disease
Author:
Affiliation:

Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • | |
  • 文章评论
    摘要:

    慢性肾疾病具有高发病率、高致死率的特点并且在全球范围内流行,但除了血液透析和肾移植外, 迄今尚无其他有效方法治愈,因此是当前严重危害人类生命健康的重大疾病之一。 干细胞是一类具有自我更新和分化为多种谱系能力的细胞,近年来研究提示,干细胞具有作为慢性肾疾病潜在治疗方法的可能。本文对间充质干细胞、胚胎干细胞和诱导多潜能干细胞三种干细胞在治疗慢性肾疾病方面的潜力进行了一个简要综述。

    Abstract:

    Chronic kidney disease (CKD) is prevalent worldwide and represents a serious threat to human life and health with a high morbidity and mortality. Currently, there are no effective curative therapeutics for CKD except hemodialysis and renal transplantation. Stem cells, which are able to self-renew and differentiate into multiple lineages, have been explored as a potentially viable treatment for CKD in recent years. In this review, the potential applications of three types of stem cells for treatment of CKD are briefly summarized, including embryonic stem cells, induced pluripotent stem cells, and mesenchymal stem cells.

    参考文献
    相似文献
    引证文献
引用本文

蒋 超,王 超,任晓楠,周晓辉.浅述干细胞治疗慢性肾疾病的潜力[J].中国比较医学杂志,2022,32(2):138~144.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-07-21
  • 在线发布日期: 2022-04-12
防诈骗提示!请勿点击不明链接或添加个人微信。编辑部所有邮箱后缀均为@cnilas.org
关闭